ACE and heart failure: These changes were significantly attenuated by the blockade of AT1 receptors (AT1R) or the inhibition of angiotensin-converting enzyme (ACE), suggesting the engagement of the RAS in the activation of the vasopressinergic system in heart failure [177,182].